#226: Effective Patient Engagement in Patient Experience Data: Practical Insights from Case Studies in Hard-to-Reach Populations
Tuesday, June 18, 2024 10:00 AM to 11:00 AM · 1 hr. (US/Pacific)
Room 15AB
05: Patient-Focused Drug Dev
Information
This forum will describe strategies for patient engagement to help design patient experience studies (PED). Case studies will illustrate the critical impact of patient engagement on the design of PED studies.
CE
ACPECMERN
Session Level
Intermediate
Featured Topics
Patient FocusedDiversity Equity and Inclusion (DEI)
Speakers
CV
Caroline Vass
Senior Economist, Health Preference AssessmentRTI Health Solutions
Bennett Levitan
Executive Director, Benefit-Risk Assessment / EpidemiologyJohnson & Johnson
Bellinda King-Kallimanis
Senior Director of Patient-Focused ResearchLungevity Foundation
Brett Hauber
Patient Preference Evidence Generation Team LeadPfizerRB
Robyn Bent
Director, Patient Focused Drug Development, OCD, CDERFDAEJ
Ellen Janssen
Director, Global Epidemiology, Benefit-Risk AssessmentJanssen Research & Development LLCRegistered attendees
Alicia Gilsenan
Vice President, EpidemiologyRTI Health SolutionsAB
Ambily Banerjee
Senior Director/Head of Diversity in Clinical TrialsJohnson and Johnson Innovative MedicineAS
Ayush Sood
Post-Doctoral Fellow, MASC, Clinical Development and Medical AffairsBoehringer-Ingelheim Pharmaceuticals, Inc.